Clonal Evolution of Endometriosis to Peritoneal Endometrioid Carcinoma via PTEN Biallelic Inactivation: A Case Report With Integrated Genomic and Pathological Profiling
Open Access
- 1 June 2026
- journal article
- case report
- Published by American Society of Clinical Oncology (ASCO) in JCO Precision Oncology
- Vol. 10 (6) , e2600056
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- 316P Capivasertib (C) + ribociclib (R) + fulvestrant (F) in patients (pts) with HR-positive/HER2-negative advanced breast cancer (ABC): CAPItello-292 phase IbESMO Open, 2025
- Endometriosis-associated Extraovarian Malignancies: A Challenging Question for the Clinician and the PathologistAnticancer Research, 2020
- Clonal Expansion and Diversification of Cancer-Associated Mutations in Endometriosis and Normal EndometriumCell Reports, 2018
- Cancer-Associated Mutations in Endometriosis without CancerNew England Journal of Medicine, 2017
- Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studiesThe Lancet Oncology, 2012
- Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.2000
- Loss of PTEN facilitates HIF-1-mediated gene expressionGenes & Development, 2000
- Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.1998